Do low titers of antibody against hepatitis B surface antigen carry a risk of viral reactivation during immunosuppressive therapy for rheumatic diseases?
Shunsuke
S
Mori
D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D014775:Virus Activation / Q000187:drug effects*
D007166:Immunosuppressive Agents